Announced Wed, 4 Mar, 2026 · 12:05 IST

Dear Sir/Maam, The Company has entered into Hospital lab Management Services Agreement with M/s. Brahma Hospital (HUF). Detailed intimation is attached. Regards Gian Life Care Limited

Business Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.6%Reaction day

₹8.13

prior close

₹7.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.7%-1.9% vs market

Healthcare Service Provider peers, median of 23sector-2.5%-2.0% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 2.0 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+7.1

10m

+7.1

15m

+7.1

30m

+7.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.6-2.7-1.9-2.5-2.0

Next day

-1.8-1.6-0.2-3.3+1.5

-3.1-1.7-1.4-2.6-0.5

-4.1-4.3+0.3-3.3-0.8

-3.1-2.1-1.0-2.4-0.7

-2.2-2.2-0.0-2.6+0.3

-5.5-5.3-0.2-4.4-1.1

15d

-22.6-3.9-18.8-7.2-15.4

-20.8-3.4-17.4-8.8-12.0

-25.6+11.9-37.5+6.9-32.5

-28.9+14.7-43.6+10.2-39.2

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gian Life Care Ltd has entered into a Hospital Lab Management Services Agreement with M/s. Brahma Hospital (HUF), a multi-specialty hospital in Roorkee, Uttarakhand. The 5-year agreement, effective from March 1, 2026, aims to strengthen the company's position in providing diagnostic and related healthcare services in the region. The tie-up is expected to add approximately INR 1 Crore in annual revenue and INR 18-20 Lakhs in net profit per year. The transaction is not a related party transaction, and the company holds no shareholding in the counterparty.

Likely market impact

Modest positive for shareholders — the agreement provides incremental, predictable revenue and profit contribution over a 5-year horizon, but the quantum (~INR 1 Cr revenue) is relatively small, so limited short-term stock impact is expected.